E-LIB Suche - Ergebnisse für: Bravaccini S

1

59P Potential of AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 a..:

Bravaccini, S. ; Virga, A. ; Gianni, C....
ESMO Open. 9 (2024) - p. 103066 , 2024

Link: https://doi.org/10.1016/..

2

AKT1, ERBB2, ESR1, KRAS, PIK3CA and TP53 alteration detecti..:

Virga, A. ; Gianni, C. ; Palleschi, M....
European Journal of Cancer. 200 (2024) - p. 113807 , 2024

Link: https://doi.org/10.1016/..

3

Impact of Ki67 and progesterone receptor on PFS with cyclin..:

Palleschi, M. ; Barzotti, E. ; Melegari, E....
European Journal of Cancer. 138 (2020) - p. S66-S67 , 2020

Link: https://doi.org/10.1016/..

4

ALK translocation detection in non‐small cell lung cancer c..:

Bravaccini, S. ; Tumedei, M. M. ; Ulivi, P....
Cytopathology. 27 (2015) 2 - p. 103-107 , 2015

Link: https://doi.org/10.1111/..

5

Differences in biological features of breast cancer between..:

Amadori, D. ; Serra, P. ; Bravaccini, S....
Breast Cancer Research and Treatment. 145 (2014) 1 - p. 177-183 , 2014

Link: https://doi.org/10.1007/..

6

New Biomarkers to Predict the Evolution ofIn SituBreast Can..:

Bravaccini, S. ; Tumedei, M. M. ; Scarpi, E....
BioMed Research International. 2014 (2014) - p. 1-7 , 2014

Link: https://doi.org/10.1155/..

7

PP 39 Multi-determinants analysis of molecular alterations ..:

Ulivi, P. ; Passardi, A. ; Capelli, L....
European Journal of Cancer. 47 (2011) - p. S32-S33 , 2011

Link: https://doi.org/10.1016/..

8

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX ..:

Fabbri, F. ; Brigliadori, G. ; Ulivi, P....
Apoptosis. 10 (2005) 5 - p. 1095-1103 , 2005

Link: https://doi.org/10.1007/..

9

Potential of telomerase expression and activity in cervical..:

Bravaccini, S ; Sanchini, M A ; Amadori, A...
Journal of Clinical Pathology. 58 (2005) 9 - p. 911-914 , 2005

Link: https://doi.org/10.1136/..

10

Follicular Lymphoma Microenvironment Traits Associated with..:

Tumedei, MM ; Piccinini, F ; Azzali, I...
info:eu-repo/semantics/altIdentifier/pmid/37373066. , 2023

Link: https://hdl.handle.net/1..

11

Combining preclinical tools and models to unravel tumor com..:

Miserocchi G ; Bocchini M ; Cortesi M...
info:eu-repo/semantics/altIdentifier/pmid/37033986. , 2023

Link: https://hdl.handle.net/1..

12

Spotlight on PSMA as a new theranostic biomarker for bladde..:

Tumedei M. M ; Ravaioli S ; Matteucci F...
info:eu-repo/semantics/altIdentifier/pmid/33963223. , 2021

Link: http://hdl.handle.net/11..

13

Expanding roles of de novo lipogenesis in breast cancer:

Simeone P ; Tacconi S ; Longo S...
info:eu-repo/semantics/altIdentifier/wos/WOS:000638517600001. , 2021

Link: http://hdl.handle.net/11..

14

The impact of progesterone receptor expression on prognosis..:

Bravaccini S ; Bronte G ; Scarpi E...
info:eu-repo/semantics/altIdentifier/pmid/32158505. , 2020

Link: http://hdl.handle.net/23..

15

Impressive long-term response with chemo-endocrine therapy ..:

Maltoni R ; Palleschi M ; Gallerani G...
info:eu-repo/semantics/altIdentifier/pmid/32541460. , 2020

Link: http://hdl.handle.net/11..